FDA to Approve Cannabis-Based Pharmaceutical for Multiple Health Conditions
GW Pharmaceuticals is expected to be given a green light for a cannabidiol drug (marijuana-based medicine) which has shown promise in the treatment of epileptic children, cutting epileptic attacks down by as much as 100% (45% average). When will the Feds admit cannabis is a medical miracle?
